Logo

ORAL RINSES: WHAT'S SAFE? WHAT'S EFFECTIVE?

Room type

Permanent

This field is required.
This field is required.
This field is required.
This field is required.
This field is required.
Required fields
If you have already registered and can't locate your registration confirmation email, click here!
The email address is incorrect. Please double-check your email address.

A confirmation email with logging details has been sent to the provided email.

System configuration test. Click here!

Agenda

TITLE:  ORAL RINSES: WHAT'S SAFE? WHAT'S EFFECTIVE?

This course is also available as a live interactive webinar scheduled monthly here: https://www.dentalceacademy.com/herb-moskowitz 

COURSE SUMMARY:   This course will analyze the efficacy and safety of current oral rinses and introduce the latest generation molecular iodine rinses. Upon the completion of this webinar, you will be provided with evidence-based studies showing the most effective rinses to protect both patients and staff.

COURSE FEE:  Complimentary

SPONSOR: ioTech International Molecular Iodine

CREDITS: This continuing education activity is designated for 1.5 credits.

AGD PACE SUBJECT CODE:  010 Basic Sciences. Pharmacotherapeutics, Emerging Technology

MODE: Electronically Mediated | Recorded Lecture - On Demand | Recorded 1.6.23 | For review 6.1.23

SPEAKER: Dr. Herb Moskowitz

AUDIENCE: Dentists, Dental Hygienists, Dental Therapists, Dental Assistants

TECHNOLOGY REQUIRED:  Mobile device, laptop or desktop with internet connection | Google Chrome Browser

LEARNING OBJECTIVES: 

  1. Review the evolution of iodine in becoming a standard of care.

  2. Learn about a technological breakthrough leading to a new class of “super” iodines​.

  3. Understand how the implementation of the new “super” iodines in your practice will benefit your patients.

  4. Compare the advantages and disadvantages of commonly used oral rinses.

  5. Describe the misconceptions related to iodine sensitivity.

  6. Learn why periodontal bacteremias are now considered a cause of cardiovascular disease.

INSTRUCTIONS: INSTRUCTIONS: This is a recorded webinar. Upon registration, a confirmation email is sent to you from no-reply@clickmeeting.com with a link to join.  You must watch the entire recording to receive CE Credit. Do not fast forward as your attendance is tracked. You may rewind, or pause. Once the webinar begins, a blue banner will appear at the top of the screen to download the handout. At the end of the recording a red banner will appear to complete the quiz. You may also close the screen, and an autogenerated email will be sent from no-reply@clickmeeting.com to complete a quiz for CE Credit, subject "Thank you for attending".  A minimum passing score of 80% is required, multiple attempts are permitted, and you will have 7 days to successfully complete. A full report and CE Credit verification will be sent to you from Dental CE Academy, email: support@dentalcenow.com. For assistance with CE Credit verification, please submit one online request here: https://www.dentalceacademy.com For technical support email: support@dentalcenow.com 
(*Note this continuing education program is followed by a  product demonstration webinar. Per AGD PACE Standards, you are not required to view the product demonstration webinar to obtain CE Credits, and you may log off if you wish by closing the screen.  Or, you may choose to stay on and watch the optional Product Demonstration.) Either way, at the conclusion of Dr. Moskowitz' CE presentation a banner will appear at top of screen to access the quiz for CE Credit. Upon successful completion of quiz/course evaluation your CE Credit Verification will appear on the screen for download/print and  will be sent to your email within 1-5 minutes. Should you require assistance with CE Credits please submit your request here: https://www.dentalceacademy.com/ceverification   If you have any questions about the subject matter, please contact the presenter, Dr. Herb Moskowitz: herbmoskowitz@iotechinternational.com 

DISCLOSURE OF SPEAKER AND FACULTY COMMERCIAL RELATIONSHIPS: According to Dental CE Academy's Conflict of Interest and Disclosure Policy, faculty and speakers for any course are expected to disclose any economic support, personal interests, or potential bias that may be perceived as creating a conflict related to the material being presented. Disclosure statements are printed in each course description and announced by moderators or individual speakers at the beginning of each presentation. This policy is intended to alert the audience to any potential bias or conflict so that participants may form their own judgments about the material being presented.

CONFLICT OF INTEREST AND FINANCIAL DISCLOSURE OF SPEAKER: This program is sponsored by ioTech International. Dr. Herb Moskowitz, DDS; is the Chairman and Co-Founder of ioTech International. He is a paid speaker and is financially associated with ioTech International.

DENTAL CE ACADEMY DISCLAIMER: The views expressed and opinions and materials presented during these live and recorded presentations represent the personal views and opinions of the individual speaker and do not necessarily represent the views and opinions of Dental CE Academy or its parent company, Virtual Dontics®. Dental CE Academy assumes no responsibility for the content of the presentations made by the individual speakers. Any suggested protocols for treatment, materials, or services may be based upon the speaker's own clinical experience and should not be construed as Dental CE Academy recommended or endorsed. Selected presentations may include exploratory research or experimental procedures and are intended for informational purposes that may lead to interest and scientific breakthroughs in the fields of dentistry.    Dental CE Academy appreciates its educators who share their knowledge and expertise. This level of dedication to dentistry allows our profession to expand and thrive and provokes necessary discussion and understanding. 

Dr. Herb Moskowitz, DDS

Dr. Herb Moskowitz is the Chairman and Co-Founder of ioTech International. He is the co-author of ioTech's U.S. patent and global patent applications. He previously founded and served as Chairman and CEO of Advanced Tissue Sciences and Life Medical Sciences, two publicly traded medical technology companies. He has also practiced clinical dentistry for more than 25 years and is a graduate of the University of Tennessee Dental School.